A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt

A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt

Background Multi- criteria decision analysis (MCDA) can assist policymakers in objectively choosing between alternative therapeutic options based on multiple value attributes. Our aim was to create an MCDA tool for the national tenders of off-patent oncology medicines in Egypt. Methods An initial li...

Full description

Bibliographic Details
Main Authors: Baher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, Randa Eldessouki, Mary Gamal, Mariam Eldebeiky, Hanaa Amer, Shimaa Akeel, Ahmad Morsy, Amira Amin, Amr Shafik, Sherif Abaza, Zoltán Kaló
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
off-patent pharmaceuticals
multi- criteria decision analysis
purchasing
oncology medicines
tendering process
mcda
Online Access:http://dx.doi.org/10.1186/s40545-022-00414-2

Internet

http://dx.doi.org/10.1186/s40545-022-00414-2

Similar Items